J4

• 基础研究 • 上一篇    下一篇

汉防己甲素逆转白血病细胞株K562/A02耐药的机制

赵殿凤1,刘子玲1,马 宁1,张永峰1,屈蓓蓓1,王志虹2,李志毅2   

  1. 1.吉林大学第一医院肿瘤治疗中心,吉林 长春 130021;2.成都康弘药业集团,四川 成都 610036
  • 收稿日期:2008-03-31 修回日期:1900-01-01 出版日期:2009-01-28 发布日期:2009-01-28
  • 通讯作者: 刘子玲

Mechanism of tetrandrine in reversion of multidrug resistance of leukemic cell line K562/A02

ZHAO Dian-feng1,LIU Zi-ling1,MA Ning1,ZHANG Yong-feng1,QU Bei-bei1,WANG Zhi-hong2,LI Zhi-yi2   

  1. 1.Center of Tumor Treatment,First Hospital,Jilin Univercity,Changchun 130021,China;2.Nakasone Pharmaceutical Group,Chengdu 610036,China
  • Received:2008-03-31 Revised:1900-01-01 Online:2009-01-28 Published:2009-01-28
  • Contact: LIU Zi-ling

摘要: 目的:研究汉防己甲素(TTD)对白血病细胞株K562/A02多药耐药(MDR)逆转的机理。方法:以白血病细胞系K562及其耐药细胞系K562/A02为TTD作用的靶细胞。细胞水平检测实验分5组(K562组、K562/A02组、K562+ADM组、K562/A02+ADM组和K562/A02+TTD+ADM组),采用MTT法检测TTD对K562和K562/A02细胞的非细胞毒性剂量,流式细胞术检测细胞内阿霉素(ADM)的浓度,基因、酶学、蛋白水平检测实验分3组(K562组、K562/A02组和K562/A02+TTD组),采用RT-PCR法检测mdr1 mRNA的表达,免疫细胞化学方法检测谷胱甘肽S转移酶π(GST-π)和拓扑异构酶Ⅱ(Topo Ⅱ)的表达水平,Western-blotting法检测P-糖蛋白(P-gp)和bcl-2表达。结果:1.562 5 mg•L-1的TTD处理K562/A02细胞后,细胞内ADM的浓度较单用ADM组明显提高(P<0.01);与空白对照组比较,K562/A02细胞内mdr1 mRNA/P-gp的表达量减少(P<0.01);GST-π和TopoⅡ表达无明显变化;凋亡抑制基因bcl-2的表达量减少(P<0.01)。结论:TTD主要通过增加细胞内ADM浓度,下调mdr1/P-gp和bcl-2表达逆转耐药。

关键词: 白血病, 汉防己甲素

Abstract: Abstract:Objective To investigate the reversal mechanism of tetrandrine (TTD) on multidrug resistance(MDR) in leukemia cell line K562/A02.Methods Human leukemia cell line K562 and multidrug-resistant cell line K562/A02 were used as the target cells.There were five groups in the examination of cellular level(K562 group,K562/A02 group,K562+ADM group,K562/A02+ADM group and K562/A02+TTD+ADM group).The non-cytotoxicity doses to cell lines K562 and K562/A02 of TTD were got by MTT assay.Using flow cytometry (FCM) assay to examine the intracellular ADM concentration.There were three groups in the examination of genic,zymologic and protein levels(K562 group,K562/A02 group and K562/A02+TTD group).The mRNA expression of MDR was measured by fluorescent quantitative reverse transcriptase polymerase chain reaction(RT-PCR).The expression levels of glutathione-S-transferase (GST-π) and topoisomerase Ⅱ(Topo Ⅱ) were determined by immunohistochemical technique.The expressions of P-glyco-protein(P-gp) and bcl-2 were observed by Western-blotting.Results The intracellular concentration of ADM in K562/A02 cells after treated with 1.562 5 mg•L-1 TTD was higher than that in ADM groups(P<0.01).Compared with blank group,the expression of mdr1 mRNA/ P-gp in K562/A02 cells reduced(P<0.01),the expressins of GST-π and Topo Ⅱ had no change,and the expression of bcl-2 reduced(P<0.01).Conclusion TTD can reverse the MDR of K562/A02 cell line by inceasing intracellular concentration of ADM and reducing the expressions of mdr1 mRNA/ P-gp and bcl-2 in K562/ A02 cells.

Key words: leukemia, tetrandrine (TTD)

中图分类号: 

  • R733.7